Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein

I. Jialal, Scott M Grundy

Research output: Contribution to journalArticle

250 Citations (Scopus)

Abstract

Much data has accumulated supporting a proatherogenic role for oxidized low density lipoprotein (Ox-LDL). Micronutrient antioxidants such as alpha- tocopherol, the principal lipid-soluble antioxidant, assume potential significance because levels can be manipulated by dietary measures without resulting in side effects. Co-incubation of LDL in vitro with alpha- tocopherol inhibits its oxidative modification. Hence the effect of dietary supplementation with alpha-tocopherol on the time course of copper-catalyzed oxidation of LDL was tested in a randomized placebo-controlled single-blind study. Two groups of 12 male subjects were given either placebo or alpha- tocopherol (800 IU/day) for a period of 12 weeks. Alpha-tocopherol therapy did not result in any side effects or exert an adverse effect on the plasma lipid and lipoprotein profile. While the lipid standardized alpha-tocopherol levels were similar at baseline, the supplemented group had 3.3-fold and 4.4- fold higher levels compared to placebo at 6 and 12 weeks, respectively. In the 15 subjects in whom both plasma and LDL alpha-tocopherol levels were quantitated, there was a significant correlation (r = 0.79, P < 0.0001). At baseline there were no significant differences in the time course curves of thiobarbituric acid-reacting substances (TBARS) activity or conjugated diene formation between the alpha-tocopherol and placebo groups. However, at both 6 and 12 weeks the mean levels of TBARS activity and conjugated diene formation were lower in the alpha-tocopherol group; the most significant differences were manifest at the 3-h time point. Also at both 6 and 12 weeks the mean rate of oxidation was lower in the alpha-tocopherol group. There was a significant inverse correlation between both the 3-h time point and the rate of oxidation with plasma lipid standardized alpha-tocopherol levels. As this study shows that alpha-tocopherol supplementation results in an increase in plasma and LDL alpha-tocopherol levels resulting in a decreased susceptibility of LDL to oxidation, these findings could have major implications in atherosclerosis prevention.

Original languageEnglish (US)
Pages (from-to)899-906
Number of pages8
JournalJournal of Lipid Research
Volume33
Issue number6
StatePublished - 1992

Fingerprint

alpha-Tocopherol
Dietary Supplements
LDL Lipoproteins
Placebos
Lipids
Plasmas
Oxidation
Antioxidants
Single-Blind Method
Micronutrients
Lipoproteins
Copper
Atherosclerosis
oxidized low density lipoprotein

Keywords

  • antioxidants
  • LDL
  • lipid peroxidation
  • modified lipoprotein
  • vitamin E

ASJC Scopus subject areas

  • Endocrinology

Cite this

Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. / Jialal, I.; Grundy, Scott M.

In: Journal of Lipid Research, Vol. 33, No. 6, 1992, p. 899-906.

Research output: Contribution to journalArticle

@article{5924582c74fc48669f9739189b0f2876,
title = "Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein",
abstract = "Much data has accumulated supporting a proatherogenic role for oxidized low density lipoprotein (Ox-LDL). Micronutrient antioxidants such as alpha- tocopherol, the principal lipid-soluble antioxidant, assume potential significance because levels can be manipulated by dietary measures without resulting in side effects. Co-incubation of LDL in vitro with alpha- tocopherol inhibits its oxidative modification. Hence the effect of dietary supplementation with alpha-tocopherol on the time course of copper-catalyzed oxidation of LDL was tested in a randomized placebo-controlled single-blind study. Two groups of 12 male subjects were given either placebo or alpha- tocopherol (800 IU/day) for a period of 12 weeks. Alpha-tocopherol therapy did not result in any side effects or exert an adverse effect on the plasma lipid and lipoprotein profile. While the lipid standardized alpha-tocopherol levels were similar at baseline, the supplemented group had 3.3-fold and 4.4- fold higher levels compared to placebo at 6 and 12 weeks, respectively. In the 15 subjects in whom both plasma and LDL alpha-tocopherol levels were quantitated, there was a significant correlation (r = 0.79, P < 0.0001). At baseline there were no significant differences in the time course curves of thiobarbituric acid-reacting substances (TBARS) activity or conjugated diene formation between the alpha-tocopherol and placebo groups. However, at both 6 and 12 weeks the mean levels of TBARS activity and conjugated diene formation were lower in the alpha-tocopherol group; the most significant differences were manifest at the 3-h time point. Also at both 6 and 12 weeks the mean rate of oxidation was lower in the alpha-tocopherol group. There was a significant inverse correlation between both the 3-h time point and the rate of oxidation with plasma lipid standardized alpha-tocopherol levels. As this study shows that alpha-tocopherol supplementation results in an increase in plasma and LDL alpha-tocopherol levels resulting in a decreased susceptibility of LDL to oxidation, these findings could have major implications in atherosclerosis prevention.",
keywords = "antioxidants, LDL, lipid peroxidation, modified lipoprotein, vitamin E",
author = "I. Jialal and Grundy, {Scott M}",
year = "1992",
language = "English (US)",
volume = "33",
pages = "899--906",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

TY - JOUR

T1 - Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein

AU - Jialal, I.

AU - Grundy, Scott M

PY - 1992

Y1 - 1992

N2 - Much data has accumulated supporting a proatherogenic role for oxidized low density lipoprotein (Ox-LDL). Micronutrient antioxidants such as alpha- tocopherol, the principal lipid-soluble antioxidant, assume potential significance because levels can be manipulated by dietary measures without resulting in side effects. Co-incubation of LDL in vitro with alpha- tocopherol inhibits its oxidative modification. Hence the effect of dietary supplementation with alpha-tocopherol on the time course of copper-catalyzed oxidation of LDL was tested in a randomized placebo-controlled single-blind study. Two groups of 12 male subjects were given either placebo or alpha- tocopherol (800 IU/day) for a period of 12 weeks. Alpha-tocopherol therapy did not result in any side effects or exert an adverse effect on the plasma lipid and lipoprotein profile. While the lipid standardized alpha-tocopherol levels were similar at baseline, the supplemented group had 3.3-fold and 4.4- fold higher levels compared to placebo at 6 and 12 weeks, respectively. In the 15 subjects in whom both plasma and LDL alpha-tocopherol levels were quantitated, there was a significant correlation (r = 0.79, P < 0.0001). At baseline there were no significant differences in the time course curves of thiobarbituric acid-reacting substances (TBARS) activity or conjugated diene formation between the alpha-tocopherol and placebo groups. However, at both 6 and 12 weeks the mean levels of TBARS activity and conjugated diene formation were lower in the alpha-tocopherol group; the most significant differences were manifest at the 3-h time point. Also at both 6 and 12 weeks the mean rate of oxidation was lower in the alpha-tocopherol group. There was a significant inverse correlation between both the 3-h time point and the rate of oxidation with plasma lipid standardized alpha-tocopherol levels. As this study shows that alpha-tocopherol supplementation results in an increase in plasma and LDL alpha-tocopherol levels resulting in a decreased susceptibility of LDL to oxidation, these findings could have major implications in atherosclerosis prevention.

AB - Much data has accumulated supporting a proatherogenic role for oxidized low density lipoprotein (Ox-LDL). Micronutrient antioxidants such as alpha- tocopherol, the principal lipid-soluble antioxidant, assume potential significance because levels can be manipulated by dietary measures without resulting in side effects. Co-incubation of LDL in vitro with alpha- tocopherol inhibits its oxidative modification. Hence the effect of dietary supplementation with alpha-tocopherol on the time course of copper-catalyzed oxidation of LDL was tested in a randomized placebo-controlled single-blind study. Two groups of 12 male subjects were given either placebo or alpha- tocopherol (800 IU/day) for a period of 12 weeks. Alpha-tocopherol therapy did not result in any side effects or exert an adverse effect on the plasma lipid and lipoprotein profile. While the lipid standardized alpha-tocopherol levels were similar at baseline, the supplemented group had 3.3-fold and 4.4- fold higher levels compared to placebo at 6 and 12 weeks, respectively. In the 15 subjects in whom both plasma and LDL alpha-tocopherol levels were quantitated, there was a significant correlation (r = 0.79, P < 0.0001). At baseline there were no significant differences in the time course curves of thiobarbituric acid-reacting substances (TBARS) activity or conjugated diene formation between the alpha-tocopherol and placebo groups. However, at both 6 and 12 weeks the mean levels of TBARS activity and conjugated diene formation were lower in the alpha-tocopherol group; the most significant differences were manifest at the 3-h time point. Also at both 6 and 12 weeks the mean rate of oxidation was lower in the alpha-tocopherol group. There was a significant inverse correlation between both the 3-h time point and the rate of oxidation with plasma lipid standardized alpha-tocopherol levels. As this study shows that alpha-tocopherol supplementation results in an increase in plasma and LDL alpha-tocopherol levels resulting in a decreased susceptibility of LDL to oxidation, these findings could have major implications in atherosclerosis prevention.

KW - antioxidants

KW - LDL

KW - lipid peroxidation

KW - modified lipoprotein

KW - vitamin E

UR - http://www.scopus.com/inward/record.url?scp=0026755677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026755677&partnerID=8YFLogxK

M3 - Article

C2 - 1512513

AN - SCOPUS:0026755677

VL - 33

SP - 899

EP - 906

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 6

ER -